RxDoctor Payments Data

Craig Chepke

Psychiatry · Huntersville, NCNPI 1831363712

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,523,467 of the $4,070,150 with a category attached, or 62.0%. It is spread thinly across 49 manufacturers, the largest accounting for just 15.6%. Among psychiatry clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,070,150in general payments, 2019–2025

Across 4,506 payments — averaging $903.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$637K
  • AbbVie$583K
  • Neurocrine Biosciences, Inc.$491K
  • Axsome Therapeutics, Inc.$452K
  • Otsuka America Pharmaceutical, Inc.$390K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$377K
  • plus $1.1M from 43 others
$39,702in research payments, 2019–2025

Across 36 payments — averaging $1102.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acadia Pharmaceuticals Inc$17K
  • Teva Pharmaceuticals USA, Inc.$12K
  • Neurocrine Biosciences, Inc.$4K
  • Biohaven Pharmaceuticals, Inc.$4K
  • Harmony Biosciences LLC$3K
  • Biohaven Pharmaceutical Holding Company Ltd.$500

What the payments were for

  • Consulting fees$1,031,59025%
  • Speaking & faculty fees$2,523,46762%
  • Travel & lodging$439,03311%
  • Food & beverage$74,1922%
  • Education$1,8680%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teva Pharmaceuticals USA, Inc.550$636,592
AbbVie(2 entities)640$583,404
Neurocrine Biosciences, Inc.591$491,198
Axsome Therapeutics, Inc.352$452,060
Otsuka America Pharmaceutical, Inc.469$390,470
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)353$376,559
E.r. Squibb & Sons, L.L.C.168$196,763
Johnson & Johnson245$179,184
Eisai Inc.173$122,262
Acadia Pharmaceuticals Inc145$113,516
Alkermes, Inc.132$110,379
Otsuka Pharmaceutical Development & Commercialization, Inc.48$90,119
Takeda Pharmaceuticals U.S.A., Inc.126$60,092
Corium, LLC55$59,069
Biogen34$31,765
H. Lundbeck A S15$28,669
Jazz Pharmaceuticals Inc.38$25,872
Noven Pharmaceuticals, Inc.20$23,456
Janssen Global Services, LLC22$21,341
Ironshore Pharmaceuticals Inc.24$11,709
Eli Lilly1$11,219
Boehringer Ingelheim6$10,082
Janssen Scientific Affairs, LLC10$8,503
Sunovion Pharmaceuticals Inc.21$7,789
Sumitomo Pharma America, Inc.2$7,603
Modernatx, Inc.3$5,661
Merck12$4,613
Lundbeck LLC46$3,082
Luye Pharma (USA) Ltd.1$2,275
Supernus Pharmaceuticals, Inc.9$2,181
Vanda Pharmaceuticals Inc.47$636
Novo Nordisk39$521
Avanir Pharmaceuticals, Inc.38$479
Neos Therapeutics, LP15$187
MDD US Operations, LLC16$163
Adlon Therapeutics L.p.7$111
Acorda Therapeutics, Inc5$98
Noven Therapeutics, LLC6$88
Arbor Pharmaceuticals, Inc.4$68
Avadel CNS Pharmaceuticals, LLC3$57
Lilly USA, LLC3$51
Adamas Pharmaceuticals, Inc.3$43
Biohaven Pharmaceuticals, Inc.2$35
Vertical Pharmaceuticals, LLC2$30
Kyowa Kirin, Inc.1$30
Sage Therapeutics, LLC1$23
Amgen1$17
Harmony Biosciences LLC1$15
Shire North American Group Inc1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,070,150 in reported general payments places this provider in the 95th percentile of 1,108 psychiatry providers in North Carolina.

See all psychiatry providers in North Carolina →

Other psychiatry in Huntersville

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →